Document is current
Any future updates will be listed below
-
Authors
Petrusca, Daniela N https://orcid.org/0000-0002-6782-2995
Toscani, Denise
Wang, Feng-Ming
Park, Cheolkyu
Crean, Colin D
Anderson, Judith L
Marino, Silvia
Mohammad, Khalid S
Zhou, Dan
Silbermann, Rebecca
Sun, Quanhong
Kurihara, Noriyoshi
Galson, Deborah L
Giuliani, Nicola
Roodman, G David
-
Funding
Funding for this research was provided by:
VA Merit Review (2I01CX000623-05)
National Cancer Institute (R01-CA209882-01A1)
Commonwealth of PA (SAP# 4100057687)
American Cancer Society (ACS-IRG # IRG-16-192-31)
- License Information
-
More Information
Article History
Received: 28 June 2018
Accepted: 19 September 2018
First Online: 4 October 2018
Ethics approval and consent to participate
: Bone marrow aspirates were obtained after informed consent in accordance with the Declaration of Helsinki from all human participants to this study. These studies were approved by the Indiana University Institutional Review Board (Indianapolis, IN, USA) (Additional file : Table S1) and University of Parma Institutional Review Board (Parma, Italy) (Additional file : Table S2).
: Not applicable.
: GDR is a member of the Amgen Denosumab Advisory Board. All other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
